Related references
Note: Only part of the references are listed.Urinary biomarkers in bladder cancer: A review of the current landscape and future directions
Kenrick Ng et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2021)
Global, regional and national burden of bladder cancer and its attributable risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease study 2019
Saeid Safiri et al.
BMJ GLOBAL HEALTH (2021)
Update on the guideline of guidelines: non-muscle-invasive bladder cancer
Jacob Taylor et al.
BJU INTERNATIONAL (2020)
A simplified nomogram to assess risk of bladder cancer in patients with a new diagnosis of microscopic hematuria
Richard S. Matulewicz et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2020)
Urinary expression of let-7c cluster as non-invasive tool to assess the risk of disease progression in patients with high grade non-muscle invasive bladder Cancer: a pilot study
Manuela Spagnuolo et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
Evaluation of a New Survivin ELISA and UBC® Rapid for the Detection of Bladder Cancer in Urine
Jan Gleichenhagen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
UBC® Rapid Test-A Urinary Point-of-Care (POC) Assay for Diagnosis of Bladder Cancer with a focus on Non-Muscle Invasive High-Grade Tumors: Results of a Multicenter-Study
Thorsten H. Ecke et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Guideline of guidelines: asymptomatic microscopic haematuria
Brian J. Linder et al.
BJU INTERNATIONAL (2018)
Urinary UBC Rapid and NMP22 Test for Bladder Cancer Surveillance in Comparison to Urinary Cytology: Results from a Prospective Single-Center Study
Renate Pichler et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2017)
UBC® Rapid Test for detection of carcinoma in situ for bladder cancer
Thorsten H. Ecke et al.
TUMOR BIOLOGY (2017)
Evaluation of the diagnostic accuracy of UBC® Rapid in bladder cancer: a Swedish multicentre study
Johan Styrke et al.
SCANDINAVIAN JOURNAL OF UROLOGY (2017)
Microscopic haematuria at time of diagnosis is associated with lower disease stage in patients with newly diagnosed bladder cancer
Daniel Ramirez et al.
BJU INTERNATIONAL (2016)
A Nomogram Derived by Combination of Demographic and Biomarker Data Improves the Noninvasive Evaluation of Patients at Risk for Bladder Cancer
Sijia Huang et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2016)
Quantified relations between exposure to tobacco smoking and bladder cancer risk: a meta-analysis of 89 observational studies
Frits H. M. van Osch et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2016)
Urinary Biomarkers for Diagnosis of Bladder Cancer A Systematic Review and Meta-analysis
Roger Chou et al.
ANNALS OF INTERNAL MEDICINE (2015)
Molecular Markers for Bladder Cancer Screening, Early Diagnosis, and Surveillance: The WHO/ICUD Consensus
Bernd J. Schmitz-Draeger et al.
UROLOGIA INTERNATIONALIS (2015)
Efficacy of antibiotic prophylaxis in cystoscopy to prevent urinary tract infection: a systematic review and meta-analysis
Herney Andres Garcia-Perdomo et al.
INTERNATIONAL BRAZ J UROL (2015)
Evaluation of a new quantitative point-of-care test platform for urine-based detection of bladder cancer
Rene Ritter et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2014)
Accuracy of the EORTC risk tables and of the CUETO scoring model to predict outcomes in non-muscle-invasive urothelial carcinoma of the bladder
E. Xylinas et al.
BRITISH JOURNAL OF CANCER (2013)
ICUD-EAU International Consultation on Bladder Cancer 2012: Non-Muscle-Invasive Urothelial Carcinoma of the Bladder
Maximilian Burger et al.
EUROPEAN UROLOGY (2013)
Accurate risk assessment of patients with asymptomatic hematuria for the presence of bladder cancer
Eugene K. Cha et al.
WORLD JOURNAL OF UROLOGY (2012)
Predicting Nonmuscle Invasive Bladder Cancer Recurrence and Progression in Patients Treated With Bacillus Calmette-Guerin: The CUETO Scoring Model
Jesus Fernandez-Gomez et al.
JOURNAL OF UROLOGY (2009)
Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: A combined analysis of 2596 patients from seven EORTC trials
RJ Sylvester et al.
EUROPEAN UROLOGY (2006)
Sensitivity and specificity of commonly available bladder tumor markers versus cytology: Results of a comprehensive literature review and meta-analyses
Y Lotan et al.
UROLOGY (2003)
Share Paper
